nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—CYP3A4—bone cancer	0.778	1	CbGaD
Pilocarpine—CYP2E1—Felbamate Metabolism—CYP3A4—bone cancer	0.00431	0.12	CbGpPWpGaD
Pilocarpine—CYP2A6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00179	0.05	CbGpPWpGaD
Pilocarpine—CHRM3—Acetylcholine regulates insulin secretion—GNA11—bone cancer	0.00156	0.0435	CbGpPWpGaD
Pilocarpine—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00141	0.0395	CbGpPWpGaD
Pilocarpine—CYP2A6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00103	0.0288	CbGpPWpGaD
Pilocarpine—CYP2A6—Xenobiotics—CYP3A4—bone cancer	0.000864	0.0241	CbGpPWpGaD
Pilocarpine—CYP2A6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000831	0.0232	CbGpPWpGaD
Pilocarpine—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000816	0.0228	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—FEV—bone cancer	0.000785	0.0219	CbGpPWpGaD
Pilocarpine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000764	0.0213	CbGpPWpGaD
Pilocarpine—CYP2A6—Fluoropyrimidine Activity—DHFR—bone cancer	0.000683	0.0191	CbGpPWpGaD
Pilocarpine—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.000683	0.0191	CbGpPWpGaD
Pilocarpine—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.000657	0.0183	CbGpPWpGaD
Pilocarpine—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000656	0.0183	CbGpPWpGaD
Pilocarpine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000618	0.0172	CbGpPWpGaD
Pilocarpine—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.000609	0.017	CbGpPWpGaD
Pilocarpine—CYP2A6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000593	0.0166	CbGpPWpGaD
Pilocarpine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.000458	0.0128	CbGpPWpGaD
Pilocarpine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000447	0.0125	CbGpPWpGaD
Pilocarpine—Hypoglycaemia—Doxorubicin—bone cancer	0.000421	0.00226	CcSEcCtD
Pilocarpine—Mood swings—Epirubicin—bone cancer	0.00042	0.00226	CcSEcCtD
Pilocarpine—CHRM1—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000418	0.0117	CbGpPWpGaD
Pilocarpine—Thrombocytopenia—Cisplatin—bone cancer	0.000416	0.00224	CcSEcCtD
Pilocarpine—Tachycardia—Cisplatin—bone cancer	0.000414	0.00223	CcSEcCtD
Pilocarpine—CHRM3—GPCRs, Other—GRM1—bone cancer	0.000413	0.0115	CbGpPWpGaD
Pilocarpine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.000413	0.0115	CbGpPWpGaD
Pilocarpine—Hyperhidrosis—Cisplatin—bone cancer	0.00041	0.00221	CcSEcCtD
Pilocarpine—Liver function test abnormal—Epirubicin—bone cancer	0.000409	0.0022	CcSEcCtD
Pilocarpine—CHRM2—GPCRs, Other—GRM1—bone cancer	0.000409	0.0114	CbGpPWpGaD
Pilocarpine—Dry skin—Epirubicin—bone cancer	0.000407	0.00219	CcSEcCtD
Pilocarpine—Anorexia—Cisplatin—bone cancer	0.000405	0.00218	CcSEcCtD
Pilocarpine—Migraine—Doxorubicin—bone cancer	0.000404	0.00217	CcSEcCtD
Pilocarpine—Affect lability—Doxorubicin—bone cancer	0.000404	0.00217	CcSEcCtD
Pilocarpine—Pancreatitis—Methotrexate—bone cancer	0.000402	0.00216	CcSEcCtD
Pilocarpine—Hypotension—Cisplatin—bone cancer	0.000397	0.00213	CcSEcCtD
Pilocarpine—Face oedema—Doxorubicin—bone cancer	0.000396	0.00213	CcSEcCtD
Pilocarpine—Gastritis—Epirubicin—bone cancer	0.000393	0.00211	CcSEcCtD
Pilocarpine—Muscular weakness—Epirubicin—bone cancer	0.000391	0.00211	CcSEcCtD
Pilocarpine—Mood swings—Doxorubicin—bone cancer	0.000389	0.00209	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000387	0.00208	CcSEcCtD
Pilocarpine—Influenza—Epirubicin—bone cancer	0.000383	0.00206	CcSEcCtD
Pilocarpine—Dysphagia—Epirubicin—bone cancer	0.000383	0.00206	CcSEcCtD
Pilocarpine—Dysuria—Methotrexate—bone cancer	0.000383	0.00206	CcSEcCtD
Pilocarpine—Paraesthesia—Cisplatin—bone cancer	0.000381	0.00205	CcSEcCtD
Pilocarpine—Liver function test abnormal—Doxorubicin—bone cancer	0.000379	0.00204	CcSEcCtD
Pilocarpine—Dyspnoea—Cisplatin—bone cancer	0.000378	0.00204	CcSEcCtD
Pilocarpine—Dry skin—Doxorubicin—bone cancer	0.000376	0.00202	CcSEcCtD
Pilocarpine—Pancreatitis—Epirubicin—bone cancer	0.000376	0.00202	CcSEcCtD
Pilocarpine—Photosensitivity reaction—Methotrexate—bone cancer	0.000374	0.00201	CcSEcCtD
Pilocarpine—Angina pectoris—Epirubicin—bone cancer	0.000373	0.00201	CcSEcCtD
Pilocarpine—Decreased appetite—Cisplatin—bone cancer	0.000369	0.00199	CcSEcCtD
Pilocarpine—Bronchitis—Epirubicin—bone cancer	0.000369	0.00198	CcSEcCtD
Pilocarpine—Pneumonia—Methotrexate—bone cancer	0.000367	0.00198	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000366	0.00197	CcSEcCtD
Pilocarpine—Gastritis—Doxorubicin—bone cancer	0.000363	0.00195	CcSEcCtD
Pilocarpine—Pain—Cisplatin—bone cancer	0.000363	0.00195	CcSEcCtD
Pilocarpine—Muscular weakness—Doxorubicin—bone cancer	0.000362	0.00195	CcSEcCtD
Pilocarpine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000359	0.01	CbGpPWpGaD
Pilocarpine—Dysuria—Epirubicin—bone cancer	0.000358	0.00193	CcSEcCtD
Pilocarpine—Stomatitis—Methotrexate—bone cancer	0.000356	0.00192	CcSEcCtD
Pilocarpine—Conjunctivitis—Methotrexate—bone cancer	0.000355	0.00191	CcSEcCtD
Pilocarpine—Influenza—Doxorubicin—bone cancer	0.000355	0.00191	CcSEcCtD
Pilocarpine—Dysphagia—Doxorubicin—bone cancer	0.000355	0.00191	CcSEcCtD
Pilocarpine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000355	0.0099	CbGpPWpGaD
Pilocarpine—Pollakiuria—Epirubicin—bone cancer	0.000354	0.00191	CcSEcCtD
Pilocarpine—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000354	0.00989	CbGpPWpGaD
Pilocarpine—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000351	0.00979	CbGpPWpGaD
Pilocarpine—Sweating—Methotrexate—bone cancer	0.00035	0.00188	CcSEcCtD
Pilocarpine—Photosensitivity reaction—Epirubicin—bone cancer	0.00035	0.00188	CcSEcCtD
Pilocarpine—Feeling abnormal—Cisplatin—bone cancer	0.00035	0.00188	CcSEcCtD
Pilocarpine—Haematuria—Methotrexate—bone cancer	0.000348	0.00187	CcSEcCtD
Pilocarpine—Pancreatitis—Doxorubicin—bone cancer	0.000348	0.00187	CcSEcCtD
Pilocarpine—Angina pectoris—Doxorubicin—bone cancer	0.000346	0.00186	CcSEcCtD
Pilocarpine—Epistaxis—Methotrexate—bone cancer	0.000344	0.00185	CcSEcCtD
Pilocarpine—Pneumonia—Epirubicin—bone cancer	0.000344	0.00185	CcSEcCtD
Pilocarpine—Bronchitis—Doxorubicin—bone cancer	0.000341	0.00184	CcSEcCtD
Pilocarpine—Body temperature increased—Cisplatin—bone cancer	0.000336	0.00181	CcSEcCtD
Pilocarpine—Stomatitis—Epirubicin—bone cancer	0.000333	0.00179	CcSEcCtD
Pilocarpine—Conjunctivitis—Epirubicin—bone cancer	0.000332	0.00179	CcSEcCtD
Pilocarpine—Urinary tract infection—Epirubicin—bone cancer	0.000332	0.00179	CcSEcCtD
Pilocarpine—Dysuria—Doxorubicin—bone cancer	0.000332	0.00178	CcSEcCtD
Pilocarpine—Hepatitis—Methotrexate—bone cancer	0.000328	0.00176	CcSEcCtD
Pilocarpine—Sweating—Epirubicin—bone cancer	0.000328	0.00176	CcSEcCtD
Pilocarpine—Pollakiuria—Doxorubicin—bone cancer	0.000328	0.00176	CcSEcCtD
Pilocarpine—Haematuria—Epirubicin—bone cancer	0.000326	0.00175	CcSEcCtD
Pilocarpine—Pharyngitis—Methotrexate—bone cancer	0.000325	0.00175	CcSEcCtD
Pilocarpine—Photosensitivity reaction—Doxorubicin—bone cancer	0.000324	0.00174	CcSEcCtD
Pilocarpine—Epistaxis—Epirubicin—bone cancer	0.000322	0.00174	CcSEcCtD
Pilocarpine—CHRM1—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000322	0.00899	CbGpPWpGaD
Pilocarpine—CHRM3—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000321	0.00896	CbGpPWpGaD
Pilocarpine—Sinusitis—Epirubicin—bone cancer	0.000321	0.00173	CcSEcCtD
Pilocarpine—Pneumonia—Doxorubicin—bone cancer	0.000318	0.00171	CcSEcCtD
Pilocarpine—CHRM2—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000318	0.00887	CbGpPWpGaD
Pilocarpine—Visual impairment—Methotrexate—bone cancer	0.000316	0.0017	CcSEcCtD
Pilocarpine—Hypersensitivity—Cisplatin—bone cancer	0.000313	0.00168	CcSEcCtD
Pilocarpine—Bradycardia—Epirubicin—bone cancer	0.000312	0.00168	CcSEcCtD
Pilocarpine—Stomatitis—Doxorubicin—bone cancer	0.000308	0.00166	CcSEcCtD
Pilocarpine—Rhinitis—Epirubicin—bone cancer	0.000308	0.00166	CcSEcCtD
Pilocarpine—Conjunctivitis—Doxorubicin—bone cancer	0.000307	0.00165	CcSEcCtD
Pilocarpine—Urinary tract infection—Doxorubicin—bone cancer	0.000307	0.00165	CcSEcCtD
Pilocarpine—Hepatitis—Epirubicin—bone cancer	0.000307	0.00165	CcSEcCtD
Pilocarpine—Eye disorder—Methotrexate—bone cancer	0.000306	0.00165	CcSEcCtD
Pilocarpine—Tinnitus—Methotrexate—bone cancer	0.000306	0.00165	CcSEcCtD
Pilocarpine—Hypoaesthesia—Epirubicin—bone cancer	0.000305	0.00164	CcSEcCtD
Pilocarpine—Asthenia—Cisplatin—bone cancer	0.000305	0.00164	CcSEcCtD
Pilocarpine—Pharyngitis—Epirubicin—bone cancer	0.000305	0.00164	CcSEcCtD
Pilocarpine—CHRM3—Regulation of insulin secretion—GNA11—bone cancer	0.000304	0.00849	CbGpPWpGaD
Pilocarpine—Sweating—Doxorubicin—bone cancer	0.000303	0.00163	CcSEcCtD
Pilocarpine—Oedema peripheral—Epirubicin—bone cancer	0.000302	0.00163	CcSEcCtD
Pilocarpine—Haematuria—Doxorubicin—bone cancer	0.000302	0.00162	CcSEcCtD
Pilocarpine—Epistaxis—Doxorubicin—bone cancer	0.000298	0.00161	CcSEcCtD
Pilocarpine—Sinusitis—Doxorubicin—bone cancer	0.000297	0.0016	CcSEcCtD
Pilocarpine—Visual impairment—Epirubicin—bone cancer	0.000296	0.00159	CcSEcCtD
Pilocarpine—Chills—Methotrexate—bone cancer	0.000294	0.00158	CcSEcCtD
Pilocarpine—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000291	0.00812	CbGpPWpGaD
Pilocarpine—CHRM3—GPCRs, Other—SMO—bone cancer	0.000291	0.00812	CbGpPWpGaD
Pilocarpine—Diarrhoea—Cisplatin—bone cancer	0.00029	0.00156	CcSEcCtD
Pilocarpine—Alopecia—Methotrexate—bone cancer	0.00029	0.00156	CcSEcCtD
Pilocarpine—Bradycardia—Doxorubicin—bone cancer	0.000289	0.00156	CcSEcCtD
Pilocarpine—CHRM2—GPCRs, Other—SMO—bone cancer	0.000288	0.00804	CbGpPWpGaD
Pilocarpine—Eye disorder—Epirubicin—bone cancer	0.000287	0.00154	CcSEcCtD
Pilocarpine—Tinnitus—Epirubicin—bone cancer	0.000286	0.00154	CcSEcCtD
Pilocarpine—Flushing—Epirubicin—bone cancer	0.000285	0.00153	CcSEcCtD
Pilocarpine—Rhinitis—Doxorubicin—bone cancer	0.000285	0.00153	CcSEcCtD
Pilocarpine—Hepatitis—Doxorubicin—bone cancer	0.000284	0.00153	CcSEcCtD
Pilocarpine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000284	0.00792	CbGpPWpGaD
Pilocarpine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000282	0.00789	CbGpPWpGaD
Pilocarpine—Hypoaesthesia—Doxorubicin—bone cancer	0.000282	0.00152	CcSEcCtD
Pilocarpine—Pharyngitis—Doxorubicin—bone cancer	0.000282	0.00152	CcSEcCtD
Pilocarpine—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00028	0.00781	CbGpPWpGaD
Pilocarpine—Oedema peripheral—Doxorubicin—bone cancer	0.00028	0.00151	CcSEcCtD
Pilocarpine—Dysgeusia—Methotrexate—bone cancer	0.000279	0.0015	CcSEcCtD
Pilocarpine—Back pain—Methotrexate—bone cancer	0.000276	0.00149	CcSEcCtD
Pilocarpine—Chills—Epirubicin—bone cancer	0.000275	0.00148	CcSEcCtD
Pilocarpine—Arrhythmia—Epirubicin—bone cancer	0.000274	0.00148	CcSEcCtD
Pilocarpine—Visual impairment—Doxorubicin—bone cancer	0.000274	0.00147	CcSEcCtD
Pilocarpine—Alopecia—Epirubicin—bone cancer	0.000271	0.00146	CcSEcCtD
Pilocarpine—Vomiting—Cisplatin—bone cancer	0.00027	0.00145	CcSEcCtD
Pilocarpine—Vision blurred—Methotrexate—bone cancer	0.000269	0.00145	CcSEcCtD
Pilocarpine—Rash—Cisplatin—bone cancer	0.000268	0.00144	CcSEcCtD
Pilocarpine—Dermatitis—Cisplatin—bone cancer	0.000267	0.00144	CcSEcCtD
Pilocarpine—Eye disorder—Doxorubicin—bone cancer	0.000265	0.00143	CcSEcCtD
Pilocarpine—Tinnitus—Doxorubicin—bone cancer	0.000265	0.00142	CcSEcCtD
Pilocarpine—Flushing—Doxorubicin—bone cancer	0.000263	0.00142	CcSEcCtD
Pilocarpine—Flatulence—Epirubicin—bone cancer	0.000263	0.00142	CcSEcCtD
Pilocarpine—Tension—Epirubicin—bone cancer	0.000262	0.00141	CcSEcCtD
Pilocarpine—Dysgeusia—Epirubicin—bone cancer	0.000262	0.00141	CcSEcCtD
Pilocarpine—Nervousness—Epirubicin—bone cancer	0.000259	0.0014	CcSEcCtD
Pilocarpine—Back pain—Epirubicin—bone cancer	0.000258	0.00139	CcSEcCtD
Pilocarpine—Muscle spasms—Epirubicin—bone cancer	0.000257	0.00138	CcSEcCtD
Pilocarpine—Leukopenia—Methotrexate—bone cancer	0.000255	0.00137	CcSEcCtD
Pilocarpine—Chills—Doxorubicin—bone cancer	0.000255	0.00137	CcSEcCtD
Pilocarpine—Arrhythmia—Doxorubicin—bone cancer	0.000254	0.00136	CcSEcCtD
Pilocarpine—Nausea—Cisplatin—bone cancer	0.000252	0.00136	CcSEcCtD
Pilocarpine—Vision blurred—Epirubicin—bone cancer	0.000252	0.00135	CcSEcCtD
Pilocarpine—Alopecia—Doxorubicin—bone cancer	0.000251	0.00135	CcSEcCtD
Pilocarpine—Cough—Methotrexate—bone cancer	0.000249	0.00134	CcSEcCtD
Pilocarpine—Agitation—Epirubicin—bone cancer	0.000245	0.00132	CcSEcCtD
Pilocarpine—Flatulence—Doxorubicin—bone cancer	0.000244	0.00131	CcSEcCtD
Pilocarpine—Arthralgia—Methotrexate—bone cancer	0.000243	0.00131	CcSEcCtD
Pilocarpine—Chest pain—Methotrexate—bone cancer	0.000243	0.00131	CcSEcCtD
Pilocarpine—Myalgia—Methotrexate—bone cancer	0.000243	0.00131	CcSEcCtD
Pilocarpine—Tension—Doxorubicin—bone cancer	0.000243	0.00131	CcSEcCtD
Pilocarpine—Dysgeusia—Doxorubicin—bone cancer	0.000242	0.0013	CcSEcCtD
Pilocarpine—Discomfort—Methotrexate—bone cancer	0.00024	0.00129	CcSEcCtD
Pilocarpine—Nervousness—Doxorubicin—bone cancer	0.00024	0.00129	CcSEcCtD
Pilocarpine—Syncope—Epirubicin—bone cancer	0.00024	0.00129	CcSEcCtD
Pilocarpine—Leukopenia—Epirubicin—bone cancer	0.000239	0.00129	CcSEcCtD
Pilocarpine—Back pain—Doxorubicin—bone cancer	0.000239	0.00129	CcSEcCtD
Pilocarpine—CHRM3—Integration of energy metabolism—GNA11—bone cancer	0.000239	0.00668	CbGpPWpGaD
Pilocarpine—Muscle spasms—Doxorubicin—bone cancer	0.000238	0.00128	CcSEcCtD
Pilocarpine—Palpitations—Epirubicin—bone cancer	0.000236	0.00127	CcSEcCtD
Pilocarpine—Confusional state—Methotrexate—bone cancer	0.000235	0.00126	CcSEcCtD
Pilocarpine—Loss of consciousness—Epirubicin—bone cancer	0.000235	0.00126	CcSEcCtD
Pilocarpine—Cough—Epirubicin—bone cancer	0.000233	0.00125	CcSEcCtD
Pilocarpine—Vision blurred—Doxorubicin—bone cancer	0.000233	0.00125	CcSEcCtD
Pilocarpine—CHRM1—G alpha (q) signalling events—GRM1—bone cancer	0.000233	0.0065	CbGpPWpGaD
Pilocarpine—CHRM3—G alpha (q) signalling events—GRM1—bone cancer	0.000232	0.00648	CbGpPWpGaD
Pilocarpine—Infection—Methotrexate—bone cancer	0.000231	0.00125	CcSEcCtD
Pilocarpine—Hypertension—Epirubicin—bone cancer	0.000231	0.00124	CcSEcCtD
Pilocarpine—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00023	0.00642	CbGpPWpGaD
Pilocarpine—Thrombocytopenia—Methotrexate—bone cancer	0.000228	0.00123	CcSEcCtD
Pilocarpine—Myalgia—Epirubicin—bone cancer	0.000227	0.00122	CcSEcCtD
Pilocarpine—Chest pain—Epirubicin—bone cancer	0.000227	0.00122	CcSEcCtD
Pilocarpine—Arthralgia—Epirubicin—bone cancer	0.000227	0.00122	CcSEcCtD
Pilocarpine—Agitation—Doxorubicin—bone cancer	0.000227	0.00122	CcSEcCtD
Pilocarpine—Anxiety—Epirubicin—bone cancer	0.000227	0.00122	CcSEcCtD
Pilocarpine—Hyperhidrosis—Methotrexate—bone cancer	0.000225	0.00121	CcSEcCtD
Pilocarpine—Discomfort—Epirubicin—bone cancer	0.000225	0.00121	CcSEcCtD
Pilocarpine—Anorexia—Methotrexate—bone cancer	0.000222	0.00119	CcSEcCtD
Pilocarpine—Syncope—Doxorubicin—bone cancer	0.000222	0.00119	CcSEcCtD
Pilocarpine—Leukopenia—Doxorubicin—bone cancer	0.000221	0.00119	CcSEcCtD
Pilocarpine—CHRM2—G alpha (i) signalling events—RGS1—bone cancer	0.000221	0.00616	CbGpPWpGaD
Pilocarpine—CHRM2—G alpha (i) signalling events—GRM4—bone cancer	0.000221	0.00616	CbGpPWpGaD
Pilocarpine—Confusional state—Epirubicin—bone cancer	0.00022	0.00118	CcSEcCtD
Pilocarpine—Palpitations—Doxorubicin—bone cancer	0.000218	0.00118	CcSEcCtD
Pilocarpine—Oedema—Epirubicin—bone cancer	0.000218	0.00117	CcSEcCtD
Pilocarpine—Hypotension—Methotrexate—bone cancer	0.000218	0.00117	CcSEcCtD
Pilocarpine—Loss of consciousness—Doxorubicin—bone cancer	0.000217	0.00117	CcSEcCtD
Pilocarpine—Infection—Epirubicin—bone cancer	0.000217	0.00117	CcSEcCtD
Pilocarpine—Cough—Doxorubicin—bone cancer	0.000216	0.00116	CcSEcCtD
Pilocarpine—Shock—Epirubicin—bone cancer	0.000214	0.00115	CcSEcCtD
Pilocarpine—Thrombocytopenia—Epirubicin—bone cancer	0.000213	0.00115	CcSEcCtD
Pilocarpine—Hypertension—Doxorubicin—bone cancer	0.000213	0.00115	CcSEcCtD
Pilocarpine—Tachycardia—Epirubicin—bone cancer	0.000213	0.00114	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000212	0.00114	CcSEcCtD
Pilocarpine—Hyperhidrosis—Epirubicin—bone cancer	0.000211	0.00113	CcSEcCtD
Pilocarpine—Insomnia—Methotrexate—bone cancer	0.000211	0.00113	CcSEcCtD
Pilocarpine—Arthralgia—Doxorubicin—bone cancer	0.00021	0.00113	CcSEcCtD
Pilocarpine—Myalgia—Doxorubicin—bone cancer	0.00021	0.00113	CcSEcCtD
Pilocarpine—Chest pain—Doxorubicin—bone cancer	0.00021	0.00113	CcSEcCtD
Pilocarpine—Anxiety—Doxorubicin—bone cancer	0.00021	0.00113	CcSEcCtD
Pilocarpine—Paraesthesia—Methotrexate—bone cancer	0.000209	0.00113	CcSEcCtD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000208	0.00581	CbGpPWpGaD
Pilocarpine—Discomfort—Doxorubicin—bone cancer	0.000208	0.00112	CcSEcCtD
Pilocarpine—Anorexia—Epirubicin—bone cancer	0.000208	0.00112	CcSEcCtD
Pilocarpine—Dyspnoea—Methotrexate—bone cancer	0.000208	0.00112	CcSEcCtD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000207	0.00579	CbGpPWpGaD
Pilocarpine—Somnolence—Methotrexate—bone cancer	0.000207	0.00111	CcSEcCtD
Pilocarpine—Dyspepsia—Methotrexate—bone cancer	0.000205	0.0011	CcSEcCtD
Pilocarpine—Hypotension—Epirubicin—bone cancer	0.000204	0.0011	CcSEcCtD
Pilocarpine—Confusional state—Doxorubicin—bone cancer	0.000203	0.00109	CcSEcCtD
Pilocarpine—Decreased appetite—Methotrexate—bone cancer	0.000202	0.00109	CcSEcCtD
Pilocarpine—Oedema—Doxorubicin—bone cancer	0.000202	0.00109	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000201	0.00108	CcSEcCtD
Pilocarpine—Infection—Doxorubicin—bone cancer	0.0002	0.00108	CcSEcCtD
Pilocarpine—Pain—Methotrexate—bone cancer	0.000199	0.00107	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000199	0.00107	CcSEcCtD
Pilocarpine—Shock—Doxorubicin—bone cancer	0.000198	0.00107	CcSEcCtD
Pilocarpine—Thrombocytopenia—Doxorubicin—bone cancer	0.000197	0.00106	CcSEcCtD
Pilocarpine—Insomnia—Epirubicin—bone cancer	0.000197	0.00106	CcSEcCtD
Pilocarpine—Tachycardia—Doxorubicin—bone cancer	0.000197	0.00106	CcSEcCtD
Pilocarpine—Paraesthesia—Epirubicin—bone cancer	0.000196	0.00105	CcSEcCtD
Pilocarpine—Hyperhidrosis—Doxorubicin—bone cancer	0.000195	0.00105	CcSEcCtD
Pilocarpine—Dyspnoea—Epirubicin—bone cancer	0.000194	0.00105	CcSEcCtD
Pilocarpine—Somnolence—Epirubicin—bone cancer	0.000194	0.00104	CcSEcCtD
Pilocarpine—Anorexia—Doxorubicin—bone cancer	0.000192	0.00103	CcSEcCtD
Pilocarpine—Feeling abnormal—Methotrexate—bone cancer	0.000192	0.00103	CcSEcCtD
Pilocarpine—Dyspepsia—Epirubicin—bone cancer	0.000192	0.00103	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Methotrexate—bone cancer	0.00019	0.00103	CcSEcCtD
Pilocarpine—Decreased appetite—Epirubicin—bone cancer	0.000189	0.00102	CcSEcCtD
Pilocarpine—Hypotension—Doxorubicin—bone cancer	0.000188	0.00101	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000188	0.00101	CcSEcCtD
Pilocarpine—Pain—Epirubicin—bone cancer	0.000186	0.001	CcSEcCtD
Pilocarpine—Constipation—Epirubicin—bone cancer	0.000186	0.001	CcSEcCtD
Pilocarpine—Abdominal pain—Methotrexate—bone cancer	0.000184	0.000991	CcSEcCtD
Pilocarpine—Body temperature increased—Methotrexate—bone cancer	0.000184	0.000991	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000184	0.000989	CcSEcCtD
Pilocarpine—Insomnia—Doxorubicin—bone cancer	0.000182	0.000982	CcSEcCtD
Pilocarpine—Paraesthesia—Doxorubicin—bone cancer	0.000181	0.000975	CcSEcCtD
Pilocarpine—CHRM1—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.00018	0.00502	CbGpPWpGaD
Pilocarpine—Dyspnoea—Doxorubicin—bone cancer	0.00018	0.000968	CcSEcCtD
Pilocarpine—Feeling abnormal—Epirubicin—bone cancer	0.00018	0.000967	CcSEcCtD
Pilocarpine—Somnolence—Doxorubicin—bone cancer	0.000179	0.000965	CcSEcCtD
Pilocarpine—CHRM3—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000179	0.00501	CbGpPWpGaD
Pilocarpine—Gastrointestinal pain—Epirubicin—bone cancer	0.000178	0.000959	CcSEcCtD
Pilocarpine—Dyspepsia—Doxorubicin—bone cancer	0.000178	0.000956	CcSEcCtD
Pilocarpine—CHRM2—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000178	0.00496	CbGpPWpGaD
Pilocarpine—Decreased appetite—Doxorubicin—bone cancer	0.000175	0.000944	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000174	0.000937	CcSEcCtD
Pilocarpine—Pain—Doxorubicin—bone cancer	0.000172	0.000928	CcSEcCtD
Pilocarpine—Constipation—Doxorubicin—bone cancer	0.000172	0.000928	CcSEcCtD
Pilocarpine—Body temperature increased—Epirubicin—bone cancer	0.000172	0.000927	CcSEcCtD
Pilocarpine—Abdominal pain—Epirubicin—bone cancer	0.000172	0.000927	CcSEcCtD
Pilocarpine—Hypersensitivity—Methotrexate—bone cancer	0.000172	0.000924	CcSEcCtD
Pilocarpine—Asthenia—Methotrexate—bone cancer	0.000167	0.000899	CcSEcCtD
Pilocarpine—Feeling abnormal—Doxorubicin—bone cancer	0.000166	0.000895	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000165	0.000888	CcSEcCtD
Pilocarpine—Pruritus—Methotrexate—bone cancer	0.000165	0.000887	CcSEcCtD
Pilocarpine—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000161	0.0045	CbGpPWpGaD
Pilocarpine—Hypersensitivity—Epirubicin—bone cancer	0.000161	0.000864	CcSEcCtD
Pilocarpine—Abdominal pain—Doxorubicin—bone cancer	0.000159	0.000858	CcSEcCtD
Pilocarpine—Body temperature increased—Doxorubicin—bone cancer	0.000159	0.000858	CcSEcCtD
Pilocarpine—Diarrhoea—Methotrexate—bone cancer	0.000159	0.000858	CcSEcCtD
Pilocarpine—Asthenia—Epirubicin—bone cancer	0.000156	0.000842	CcSEcCtD
Pilocarpine—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.000154	0.00431	CbGpPWpGaD
Pilocarpine—Pruritus—Epirubicin—bone cancer	0.000154	0.00083	CcSEcCtD
Pilocarpine—Dizziness—Methotrexate—bone cancer	0.000154	0.000829	CcSEcCtD
Pilocarpine—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000153	0.00426	CbGpPWpGaD
Pilocarpine—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.000151	0.00421	CbGpPWpGaD
Pilocarpine—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.000151	0.00421	CbGpPWpGaD
Pilocarpine—CHRM1—G alpha (q) signalling events—GNA11—bone cancer	0.00015	0.00419	CbGpPWpGaD
Pilocarpine—CHRM3—G alpha (q) signalling events—GNA11—bone cancer	0.000149	0.00417	CbGpPWpGaD
Pilocarpine—Diarrhoea—Epirubicin—bone cancer	0.000149	0.000803	CcSEcCtD
Pilocarpine—Hypersensitivity—Doxorubicin—bone cancer	0.000149	0.0008	CcSEcCtD
Pilocarpine—Vomiting—Methotrexate—bone cancer	0.000148	0.000797	CcSEcCtD
Pilocarpine—Rash—Methotrexate—bone cancer	0.000147	0.00079	CcSEcCtD
Pilocarpine—Dermatitis—Methotrexate—bone cancer	0.000147	0.00079	CcSEcCtD
Pilocarpine—Headache—Methotrexate—bone cancer	0.000146	0.000785	CcSEcCtD
Pilocarpine—Asthenia—Doxorubicin—bone cancer	0.000145	0.000779	CcSEcCtD
Pilocarpine—Dizziness—Epirubicin—bone cancer	0.000144	0.000776	CcSEcCtD
Pilocarpine—Pruritus—Doxorubicin—bone cancer	0.000143	0.000768	CcSEcCtD
Pilocarpine—CHRM1—Circadian rythm related genes—GNA11—bone cancer	0.000142	0.00395	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—EZH2—bone cancer	0.000141	0.00394	CbGpPWpGaD
Pilocarpine—Vomiting—Epirubicin—bone cancer	0.000139	0.000746	CcSEcCtD
Pilocarpine—Nausea—Methotrexate—bone cancer	0.000138	0.000745	CcSEcCtD
Pilocarpine—Diarrhoea—Doxorubicin—bone cancer	0.000138	0.000743	CcSEcCtD
Pilocarpine—Rash—Epirubicin—bone cancer	0.000137	0.00074	CcSEcCtD
Pilocarpine—Dermatitis—Epirubicin—bone cancer	0.000137	0.000739	CcSEcCtD
Pilocarpine—Headache—Epirubicin—bone cancer	0.000137	0.000735	CcSEcCtD
Pilocarpine—CHRM1—GPCR ligand binding—GRM4—bone cancer	0.000135	0.00378	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—GRM4—bone cancer	0.000135	0.00377	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000134	0.00375	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000134	0.00373	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—GRM4—bone cancer	0.000134	0.00373	CbGpPWpGaD
Pilocarpine—Dizziness—Doxorubicin—bone cancer	0.000133	0.000718	CcSEcCtD
Pilocarpine—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000132	0.00369	CbGpPWpGaD
Pilocarpine—Nausea—Epirubicin—bone cancer	0.000129	0.000697	CcSEcCtD
Pilocarpine—Vomiting—Doxorubicin—bone cancer	0.000128	0.00069	CcSEcCtD
Pilocarpine—Rash—Doxorubicin—bone cancer	0.000127	0.000684	CcSEcCtD
Pilocarpine—Dermatitis—Doxorubicin—bone cancer	0.000127	0.000684	CcSEcCtD
Pilocarpine—Headache—Doxorubicin—bone cancer	0.000126	0.00068	CcSEcCtD
Pilocarpine—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000122	0.00341	CbGpPWpGaD
Pilocarpine—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.00012	0.00336	CbGpPWpGaD
Pilocarpine—Nausea—Doxorubicin—bone cancer	0.00012	0.000645	CcSEcCtD
Pilocarpine—CHRM1—GPCR ligand binding—GRM1—bone cancer	0.000117	0.00328	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—GRM1—bone cancer	0.000117	0.00327	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—GRM1—bone cancer	0.000116	0.00324	CbGpPWpGaD
Pilocarpine—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000104	0.00292	CbGpPWpGaD
Pilocarpine—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000103	0.00288	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—NDUFA12—bone cancer	9.26e-05	0.00259	CbGpPWpGaD
Pilocarpine—CHRM1—Regulation of Actin Cytoskeleton—BRAF—bone cancer	8.94e-05	0.0025	CbGpPWpGaD
Pilocarpine—CHRM3—Regulation of Actin Cytoskeleton—BRAF—bone cancer	8.92e-05	0.00249	CbGpPWpGaD
Pilocarpine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—bone cancer	8.83e-05	0.00247	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—NDUFA12—bone cancer	8.69e-05	0.00243	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—SMO—bone cancer	8.27e-05	0.00231	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—SMO—bone cancer	8.24e-05	0.0023	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—SMO—bone cancer	8.16e-05	0.00228	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—CDK4—bone cancer	7.96e-05	0.00222	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—NT5C3A—bone cancer	7.67e-05	0.00214	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—RGS1—bone cancer	7.65e-05	0.00214	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—GRM4—bone cancer	7.65e-05	0.00214	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—GRM4—bone cancer	7.63e-05	0.00213	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—RGS1—bone cancer	7.63e-05	0.00213	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—GRM4—bone cancer	7.55e-05	0.00211	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—RGS1—bone cancer	7.55e-05	0.00211	CbGpPWpGaD
Pilocarpine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	7.48e-05	0.00209	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—NDUFA12—bone cancer	7.32e-05	0.00204	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—NT5C3A—bone cancer	7.2e-05	0.00201	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—GRM4—bone cancer	6.95e-05	0.00194	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—RGS1—bone cancer	6.95e-05	0.00194	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—RGS1—bone cancer	6.92e-05	0.00193	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—GRM4—bone cancer	6.92e-05	0.00193	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—GRM4—bone cancer	6.86e-05	0.00192	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—RGS1—bone cancer	6.86e-05	0.00192	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—GRM1—bone cancer	6.63e-05	0.00185	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—GRM1—bone cancer	6.61e-05	0.00185	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—GRM1—bone cancer	6.55e-05	0.00183	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—JUN—bone cancer	6.2e-05	0.00173	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—NT5C3A—bone cancer	6.06e-05	0.00169	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—GRM1—bone cancer	6.02e-05	0.00168	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—GRM1—bone cancer	6e-05	0.00168	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—GRM1—bone cancer	5.95e-05	0.00166	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—JUN—bone cancer	5.13e-05	0.00143	CbGpPWpGaD
Pilocarpine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—bone cancer	5.12e-05	0.00143	CbGpPWpGaD
Pilocarpine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—bone cancer	5.1e-05	0.00143	CbGpPWpGaD
Pilocarpine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—bone cancer	5.06e-05	0.00141	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.84e-05	0.00135	CbGpPWpGaD
Pilocarpine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.78e-05	0.00133	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—GNA11—bone cancer	4.27e-05	0.00119	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—GNA11—bone cancer	4.26e-05	0.00119	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—SMO—bone cancer	4.24e-05	0.00119	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—SMO—bone cancer	4.23e-05	0.00118	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—GNA11—bone cancer	4.22e-05	0.00118	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—SMO—bone cancer	4.19e-05	0.00117	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—GRM4—bone cancer	4.1e-05	0.00115	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—RGS1—bone cancer	4.1e-05	0.00115	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—GRM4—bone cancer	4.09e-05	0.00114	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—RGS1—bone cancer	4.09e-05	0.00114	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—GRM4—bone cancer	4.05e-05	0.00113	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—RGS1—bone cancer	4.05e-05	0.00113	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—GNA11—bone cancer	3.88e-05	0.00108	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—IL3—bone cancer	3.87e-05	0.00108	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—GNA11—bone cancer	3.87e-05	0.00108	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—IL3—bone cancer	3.86e-05	0.00108	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—GNA11—bone cancer	3.83e-05	0.00107	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—IL3—bone cancer	3.82e-05	0.00107	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	3.82e-05	0.00107	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	3.81e-05	0.00106	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—GRM1—bone cancer	3.56e-05	0.000994	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—GRM1—bone cancer	3.55e-05	0.00099	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL3—bone cancer	3.52e-05	0.000983	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—GRM1—bone cancer	3.51e-05	0.000981	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL3—bone cancer	3.51e-05	0.00098	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL3—bone cancer	3.47e-05	0.00097	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NDUFA12—bone cancer	3.4e-05	0.000948	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—TP53—bone cancer	3.38e-05	0.000945	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ENO2—bone cancer	3.36e-05	0.000939	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ENO2—bone cancer	3.15e-05	0.00088	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—DHFR—bone cancer	3.12e-05	0.000871	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—DHFR—bone cancer	2.92e-05	0.000817	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GNA11—bone cancer	2.91e-05	0.000814	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NT5C3A—bone cancer	2.81e-05	0.000786	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GNA11—bone cancer	2.73e-05	0.000763	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ENO2—bone cancer	2.66e-05	0.000742	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CYP3A4—bone cancer	2.64e-05	0.000738	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SMO—bone cancer	2.51e-05	0.0007	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SMO—bone cancer	2.5e-05	0.000698	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYP3A4—bone cancer	2.48e-05	0.000692	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SMO—bone cancer	2.47e-05	0.000691	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—DHFR—bone cancer	2.46e-05	0.000688	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GNA11—bone cancer	2.3e-05	0.000643	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—GNA11—bone cancer	2.29e-05	0.00064	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—GNA11—bone cancer	2.29e-05	0.000638	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—GNA11—bone cancer	2.26e-05	0.000632	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GSTP1—bone cancer	2.26e-05	0.000631	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ATF1—bone cancer	2.13e-05	0.000595	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ATF1—bone cancer	2.12e-05	0.000593	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GSTP1—bone cancer	2.12e-05	0.000592	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ATF1—bone cancer	2.1e-05	0.000588	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP3A4—bone cancer	2.09e-05	0.000583	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL3—bone cancer	2.08e-05	0.00058	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL3—bone cancer	2.07e-05	0.000579	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL3—bone cancer	2.05e-05	0.000573	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GSTP1—bone cancer	1.79e-05	0.000499	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TGFBR2—bone cancer	1.78e-05	0.000496	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TGFBR2—bone cancer	1.77e-05	0.000495	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TGFBR2—bone cancer	1.75e-05	0.00049	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IGF1R—bone cancer	1.67e-05	0.000467	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IGF1R—bone cancer	1.67e-05	0.000466	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IGF1R—bone cancer	1.65e-05	0.000461	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ENO2—bone cancer	1.23e-05	0.000344	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KIT—bone cancer	1.21e-05	0.000339	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KIT—bone cancer	1.21e-05	0.000338	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KIT—bone cancer	1.2e-05	0.000334	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PTGS2—bone cancer	1.17e-05	0.000327	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—DHFR—bone cancer	1.14e-05	0.000319	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—BRAF—bone cancer	1.14e-05	0.000318	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—BRAF—bone cancer	1.14e-05	0.000317	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—BRAF—bone cancer	1.13e-05	0.000314	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—EGFR—bone cancer	1.11e-05	0.000309	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—EGFR—bone cancer	1.1e-05	0.000308	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PTGS2—bone cancer	1.1e-05	0.000307	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—EGFR—bone cancer	1.09e-05	0.000305	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GNA11—bone cancer	1.07e-05	0.000298	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MDM2—bone cancer	9.55e-06	0.000267	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MDM2—bone cancer	9.52e-06	0.000266	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MDM2—bone cancer	9.43e-06	0.000263	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PTGS2—bone cancer	9.25e-06	0.000258	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—JUN—bone cancer	8.3e-06	0.000232	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTP1—bone cancer	8.28e-06	0.000231	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—JUN—bone cancer	8.28e-06	0.000231	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—JUN—bone cancer	8.2e-06	0.000229	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MMP9—bone cancer	8.08e-06	0.000226	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MMP9—bone cancer	8.05e-06	0.000225	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MMP9—bone cancer	7.98e-06	0.000223	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EGFR—bone cancer	6.53e-06	0.000182	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EGFR—bone cancer	6.51e-06	0.000182	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EGFR—bone cancer	6.44e-06	0.00018	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TP53—bone cancer	5.48e-06	0.000153	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TP53—bone cancer	5.46e-06	0.000153	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TP53—bone cancer	5.41e-06	0.000151	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PTGS2—bone cancer	4.29e-06	0.00012	CbGpPWpGaD
